| $350M | ||
| $217M | ||
| $172M | ||
| $109M | ||
| $107M | ||
| $104M |
Buys | $0 | 0 | 0 |
Sells | $47,785,597 | 10 | 100 |
| Tuer Patrick William | EVP, Chief Operating Officer | 0 | $0 | 2 | $373,076 | $-373,076 |
| Price Andrew L | Chief Accounting Officer | 0 | $0 | 1 | $630,166 | $-630,166 |
| Fay Edmund | Sr. Vice Pres. and Treasurer | 0 | $0 | 1 | $1.28M | $-1.28M |
| Darby John Patrick | EVP, Gen Counsel & Secretary | 0 | $0 | 2 | $1.71M | $-1.71M |
| COLTHARP DOUGLAS E | EVP & Chief Financial Officer | 0 | $0 | 2 | $5.32M | $-5.32M |
| Tarr Mark J | President & CEO | 0 | $0 | 2 | $38.47M | $-38.47M |
Encompass Health Corporation delivers a range of post-acute healthcare services across the United States, offered both in dedicated facilities and directly within patients' homes. The company's operations are divided into two primary divisions: Inpatient Rehabilitation, and Home Health and Hospice. Its Inpatient Rehabilitation division specializes in providing focused recovery treatment, available on an inpatient or outpatient basis. This care is designed for individuals recuperating from significant health challenges such as strokes, …
Over the last 12 months, insiders at Encompass Health Corporation have bought $0 and sold $47.79M worth of Encompass Health Corporation stock.
On average, over the past 5 years, insiders at Encompass Health Corporation have bought $187,033 and sold $16.32M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $167,460 was made by CARMICHAEL GREG D (director) on 2024‑05‑03.
| 2026-08-31 | Sale | Darby John Patrick | EVP, Gen Counsel & Secretary | 4,858 0.005% | $121.09 | $588,255 | +1.93% | |
| 2026-08-31 | Sale | Price Andrew L | Chief Accounting Officer | 5,211 0.0053% | $120.93 | $630,166 | +1.93% | |
| 2026-08-10 | Sale | Tarr Mark J | President & CEO | 173,148 0.1748% | $125.47 | $21.72M | -2.95% | |
| 2026-08-10 | Sale | Darby John Patrick | EVP, Gen Counsel & Secretary | 8,906 0.009% | $125.95 | $1.12M | -2.95% | |
| 2026-08-10 | Sale | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | 18,869 0.019% | $125.38 | $2.37M | -2.95% | |
| 2026-05-15 | Sale | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | 27,694 0.028% | $106.83 | $2.96M | +12.90% | |
| 2026-05-11 | Sale | Tuer Patrick William | EVP, Chief Operating Officer | 682 0.0007% | $104.56 | $71,310 | +14.40% | |
| 2026-03-09 | Sale | Fay Edmund | Sr. Vice Pres. and Treasurer | 11,937 0.0119% | $107.00 | $1.28M | +1.63% | |
| 2026-02-11 | Sale | Tarr Mark J | President & CEO | 150,000 0.1467% | $111.64 | $16.75M | -4.31% | |
| 2026-02-10 | Sale | Tuer Patrick William | EVP, Chief Operating Officer | 2,804 0.0028% | $107.62 | $301,766 | -0.38% | |
| 2025-08-27 | Sale | Tuer Patrick William | EVP, Chief Operating Officer | 1,020 0.001% | $123.59 | $126,062 | -12.50% | |
| 2025-05-20 | Sale | Tarr Mark J | President & CEO | 118,384 0.1173% | $121.53 | $14.39M | -7.80% | |
| 2025-05-06 | Sale | Charbonneau Elissa Joy | Chief Medical Officer | 4,279 0.0042% | $116.61 | $498,974 | -2.76% | |
| 2025-04-29 | Sale | Darby John Patrick | EVP, Gen Counsel & Secretary | 10,000 0.0098% | $114.79 | $1.15M | -1.12% | |
| 2025-04-29 | Sale | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | 43,575 0.0429% | $115.15 | $5.02M | -1.12% | |
| 2025-02-13 | Sale | Price Andrew L | Chief Accounting Officer | 5,042 0.005% | $98.29 | $495,578 | +15.07% | |
| 2024-08-13 | Sale | COLTHARP DOUGLAS E | EVP & Chief Financial Officer | 12,260 0.0121% | $86.34 | $1.06M | +15.44% | |
| 2024-05-24 | Sale | Charbonneau Elissa Joy | Chief Medical Officer | 10,000 0.01% | $85.02 | $850,200 | +14.00% | |
| 2024-05-06 | Sale | Darby John Patrick | EVP, Gen Counsel & Secretary | 14,543 0.0143% | $83.94 | $1.22M | +12.42% | |
| 2024-05-03 | CARMICHAEL GREG D | director | 2,000 0.002% | $83.73 | $167,460 | +14.08% |
| Tarr Mark J | President & CEO | 267814 0.2715% | $36.1M | 2 | 16 | +10.63% |
| Fay Edmund | Sr. Vice Pres. and Treasurer | 89325 0.0905% | $12.04M | 1 | 3 | +11.88% |
| COLTHARP DOUGLAS E | EVP & Chief Financial Officer | 50508 0.0512% | $6.81M | 1 | 7 | +14.44% |
| GRINNEY JAY | Pres & Chief Executive Officer | 1118629 1.1339% | $150.78M | 4 | 8 | +10.83% |
| Anthony April Kaye Bullock | CEO & President, Home Health | 191740 0.1944% | $25.84M | 2 | 0 | +11.4% |
| Workman John L | Chief Financial Officer | 96705 0.098% | $13.03M | 4 | 0 | <0.0001% |
| STRONG GEORGE H | director | 89217 0.0904% | $12.03M | 1 | 0 | +3.92% |
| CHIDSEY JOHN | director | 88412 0.0896% | $11.92M | 1 | 0 | +16.89% |
| HANSON JON F | director | 74415 0.0754% | $10.03M | 1 | 1 | +0.72% |
| HIGDON LEO I JR | director | 73738 0.0747% | $9.94M | 3 | 0 | +9.57% |
| CURL YVONNE M | director | 71555 0.0725% | $9.64M | 2 | 0 | +19.54% |
| CORRELL DONALD L | director | 70568 0.0715% | $9.51M | 1 | 1 | +25.68% |
| Whittington John P | Gen. Counsel & Secretary | 52857 0.0536% | $7.12M | 3 | 0 | +8.29% |
| BLECHSCHMIDT EDWARD A | director | 52749 0.0535% | $7.11M | 7 | 0 | +16.18% |
| SHAW L EDWARD JR | director | 26653 0.027% | $3.59M | 2 | 0 | <0.0001% |
| Clohan Dexanne B | SVP & Chief Medical Officer | 20500 0.0208% | $2.76M | 1 | 0 | +86.33% |
| CARMICHAEL GREG D | director | 17050 0.0173% | $2.3M | 2 | 0 | +14.27% |
| MAUPIN JOHN E JR D D S | director | 15898 0.0161% | $2.14M | 1 | 0 | +21.56% |
| ELSON CHARLES M | director | 14557 0.0148% | $1.96M | 1 | 0 | +0.72% |
| HERMAN JOAN E | director | 13590 0.0138% | $1.83M | 1 | 0 | +13.76% |
| Charbonneau Elissa Joy | Chief Medical Officer | 11958 0.0121% | $1.61M | 1 | 4 | +19.02% |
| KATZ LESLYE G | director | 6118 0.0062% | $824,645.22 | 1 | 0 | +17.46% |
| Williams Terrance | director | 5258 0.0053% | $708,725.82 | 1 | 0 | +11.13% |
| O'Connor Kevin J. | 3436 0.0035% | $463,138.44 | 1 | 0 | <0.0001% |
| Increased Positions | 267 | +34.5% | 12M | +12.57% |
| Decreased Positions | 347 | -44.83% | 8M | -8.8% |
| New Positions | 80 | New | 2M | New |
| Sold Out Positions | 80 | Sold Out | 2M | Sold Out |
| Total Postitions | 694 | -10.34% | 98M | +3.76% |
| Vanguard Group Inc | $1.09M | 10.14% | 10.24M | -140,087 | -1.35% | 2025-09-30 |
| Blackrock, Inc. | $1.05M | 9.78% | 9.88M | +3,750 | +0.04% | 2025-09-30 |
| Invesco Ltd. | $545,329.00 | 5.08% | 5.13M | -512,404 | -9.09% | 2025-09-30 |
| Price T Rowe Associates Inc /Md/ | $410,292.00 | 3.82% | 3.86M | +2M | +174% | 2025-09-30 |
| State Street Corp | $327,774.00 | 3.05% | 3.08M | -24,308 | -0.78% | 2025-09-30 |
| Wellington Management Group Llp | $295,858.00 | 2.75% | 2.78M | -744,161 | -21.11% | 2025-09-30 |
| Alliancebernstein L.P. | $267,614.00 | 2.49% | 2.52M | +476,564 | +23.37% | 2025-09-30 |
| T. Rowe Price Investment Management, Inc. | $227,746.00 | 2.12% | 2.14M | -34,673 | -1.59% | 2025-09-30 |
| Fuller & Thaler Asset Management, Inc. | $219,336.00 | 2.04% | 2.06M | +238,214 | +13.06% | 2025-09-30 |
| Geode Capital Management, Llc | $192,343.00 | 1.79% | 1.81M | +34,695 | +1.96% | 2025-09-30 |